Canadian soldiers used as `guinea pigs'?

June 1999
CMAJ: Canadian Medical Association Journal;6/29/99, Vol. 160 Issue 13, p1814
Academic Journal
States that an unapproved antimalarial drug, Mefloquine, was given to Canadian soldiers, who were bound for Somalia. Concern that prescribed safety-monitoring protocol was not followed during clinical trials in 1992-1993; Common adverse effects.


Related Articles

  • Full Disclosure and Conflicts of Interest. Wechsler, Jill // Applied Clinical Trials;Jul2000, Vol. 9 Issue 7, p22 

    Focuses on efforts to increase safeguards for people participating in clinical trials in the United States. Concerns over the adequacy of investigator financial disclosure requirements; Call made by the Department of Health and Human Services for a clarification of policies to avoid conflicts...

  • How to Find a Trial. Smith, Ian K. // Time International (South Pacific Edition);11/22/99, Issue 47, p76 

    Offers information on patient enrollment in clinical drug trials. Researchers' need for patients as well as patients' need for treatment; Reasons adults do not participate in clinical drug trials; Where to locate trials. INSETS: Ace-ing It;Inside Information;Minitel Mini-Stroke;Couch Potatoes...

  • Dying for a Cure. Kaplan, Sheila; Brownlee, Shannon // U.S. News & World Report;10/11/99, Vol. 127 Issue 14, p34 

    Offers information on the difficulties of clinical trials of experimental drugs in the United States. Problems with the trials, including neglect to report reactions to the drugs and failure by doctors to inform patients of the benefits and risks of a study; Effects of these problems, including...

  • Running an international paediatric non-commercial clinical trial. Osborne, J. P.; O'Callaghan, F. J. K. // Archives of Disease in Childhood;Sep2009, Vol. 94 Issue 9, p729 

    The current regulations for conducting non-commercial clinical trials in Europe are many and complex. These are explored from the perspective of a UK based non-commercial international clinical trial. The reasons for the difficulties encountered are discussed and suggestions made as to how best...

  • Clinical trials in India: ethical concerns. Chatterjee, Patralekha // Bulletin of the World Health Organization;Aug2008, Vol. 86 Issue 8, p581 

    The article reports on the ethics of clinical trials in India. The country has become a popular site for the clinical trials business which is estimated to amount to one billion dollars by 2010. India offers drug companies several benefits including lower operation costs, qualified workers, and...

  • How experiences become data: the process of eliciting adverse event, medical history and concomitant medication reports in antimalarial and antiretroviral interaction trials. Allen, Elizabeth N.; Mushi, Adiel K.; Massawe, Isolide S.; Vestergaard, Lasse S.; Lemnge, Martha; Staedke, Sarah G.; Mehta, Ushma; Barnes, Karen I.; Chandler, Clare I. R. // BMC Medical Research Methodology;2013, Vol. 13 Issue 1, p1 

    Background Accurately characterizing a drug's safety profile is essential. Trial harm and tolerability assessments rely, in part, on participants' reports of medical histories, adverse events (AEs), and concomitant medications. Optimal methods for questioning participants are unclear, but...

  • Conducting Trials in Croatia. Aralica, Josip // Applied Clinical Trials;Nov2009, Vol. 18 Issue 11, p46 

    The article reports on the clinical research projects in Croatia while not being part of the European Union (EU). It mentions that European countries, even if not part of the EU, is not a hindrance to producing high-quality clinical research and meeting the target for the number of subjects....

  • Great Expectations: CROs Face Change in Italy. Corrado, Mario // Applied Clinical Trials;Nov2009, Vol. 18 Issue 11, p50 

    The article reports on the turbulent period of the clinical trials in Italy. It states that the country has a heterogeneous topology of the Contract Research Organizations (CRO) while the number of new trials per year has increased consistently from 500 in 2000 to 800 in 2007. On the other hand,...

  • EDC Acceptance in Japan. Brock, Andy; McNulty, Kevin; Summer, Maria // Applied Clinical Trials;Nov2009, Vol. 18 Issue 11, p56 

    The article reports on the use of electronic data capture (EDC) in clinical trials in Japan. It cites that the country was once lagging behind its regional competitors in the Asia-Pacific drug development market, but with its use of the EDC, it has become a force in the region in terms of drug...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics